MiRNA-expression in Tonsillar Squamous Cell Carcinomas in Relation to HPV Infection and Expression of the Antileukoproteinase SLPI
Overview
Oncology
Authors
Affiliations
The aim of this study was to determine if micro-(mi-)RNAs are involved in the previously reported inverse correlation between the antileukoproteinase SLPI, HPV, and smoking habit of head and neck squamous cells carcinoma (HNSCC) patients. HPV-status and SLPI-protein expression were determined in tonsillar SCC (TSCC; n=126). Differentially expressed miRNAs dependent on HPV-status and SLPI-expression were detected by microarray; possible binding-sites in SLPI- and HPVE6-mRNAs were determined in silico. Survival rates were estimated testing prognostic values of HPV-status, SLPI- and miRNA-expression. miRNA-array identified 24 up-regulated and 10 down-regulated miRNAs in HPV-positive versus HPV-negative TSCC (p<0.01; HPV-positivity: 42.1%). HPV-positivity resulted in two up-regulated miRNAs in SLPI-positive TSCC. Of 16 further miRNAs, eight miRNAs were up- and eight were down-regulated in SLPI-negative TSCC. RT-q-PCR-validation of the four most differentially expressed miRNAs showed that miR-363 is expressed strongest in SLPI-negative/HPV-positive TSSC. In silico-analysis of all differentially expressed miRNAs identified miR-363, miR-210, miR-130a, and miR-181a with possible binding sites in the HPV16-E6-mRNA, but none were predicted in the SLPI-mRNA. HPV-positivity, low SLPI-levels and high miR-363-levels are significantly associated with better survival rates. The data presented here show that miR-363 is associated with HPV-positive/SPLI-negative TSCC. The prognostic value of miR-363 suggests a role in the assumed inverse correlation of smoking and SPLI-expression in the mode of HPV-infections in tonsillar but possibly also other HNSCC.
Dysregulated microRNA Expression Relevant to Promoter Mutations in Tonsil Cancer-A Pilot Study.
Kwon M, Park H, Lee J, Kim E, Kim N, Nam E Life (Basel). 2023; 13(10).
PMID: 37895471 PMC: 10608590. DOI: 10.3390/life13102090.
Guo D, Yang M, Li S, Zhu W, Chen M, Pan J Front Oncol. 2023; 13:1122982.
PMID: 37064141 PMC: 10090466. DOI: 10.3389/fonc.2023.1122982.
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.
Thomaidou A, Batsaki P, Adamaki M, Goulielmaki M, Baxevanis C, Zoumpourlis V Int J Mol Sci. 2022; 23(15).
PMID: 35897831 PMC: 9367895. DOI: 10.3390/ijms23158257.
Ghigo A, Prono G, Riccardi E, De Rose V Int J Mol Sci. 2021; 22(4).
PMID: 33669352 PMC: 7920244. DOI: 10.3390/ijms22041952.
Quabius E, Loehr J, Haaser D, Gunther V, Maass N, Rocken C Transl Oncol. 2018; 12(1):36-42.
PMID: 30267960 PMC: 6161366. DOI: 10.1016/j.tranon.2018.09.004.